Daniella Kranjac, ChEng, MBA
Co-Founder & Managing Director
Daniella Kranjac has been building life sciences businesses, developing and commercializing life sciences products for 20 years. Having co-founded Wave Biotech LLC from her dormitory room, she and a partner drove the start-up, growth and commercialization of a highly disruptive technology. As Vice President of the organization, Daniella established a high growth company with significant brand recognition, and led the group to a successful exit and acquisition by GE Healthcare in 2007.
At GE Healthcare, Daniella held a variety of strategic, M&A and business development roles. One of her most notable achievements is the success in an entrepreneurial group within the broader GE Healthcare, where a focus on integrating the acquired Xcellerex business enabled global commercialization of a several hundred million dollar enterprise solutions business. Her extensive business development, negotiations and deal-making experience with multinational biopharma and governments in developed and emerging markets provides Dynamk with a broad network of colleagues, customers, innovators and key opinion leaders.
Ms. Kranjac’s unique perspective on the global market is owed to varied experiences in pharma, biologics and biosimilars, vaccines and cell therapies as these markets have evolved in the United States, Europe, Latin America, Brazil, Turkey, Russia, China and the Middle East. She has consistently worked to foster strong client relationships and recognition among industry thought leaders, and has a deep expertise in product management and positioning, sales, business development and internal commercial operations.
She holds a B.E. in Chemical Engineering from Stevens Institute of Technology and an Executive MBA from New York University Stern School of Business and has attended Harvard Business School Executive Education Courses in Private Equity & Venture Capital.
Daniella’s mission is to help companies reach their full potential through access to capital, strategy, business development and flawless commercial execution. She is a passionate supporter of women in STEM (Science, Technology, Engineering & Mathematics). Daniella currently serves on the boards of Envisagenics, FloDesign Sonics and Stevens Institute of Technology, where she is a Charter Member of the Board of Trustees.
Career Background and Education
Dynamk Capital LLC
Managing Partner & Co-Founder, 2016-present
Dynamk Consulting LLC
GE Healthcare Life Sciences
Global Head of Enterprise Solutions, 2013-2015
Head of Business Development, 2010-2013
Global Strategic Marketing Leader, 2009-2010
Head of Global Commercial Operations & Integration Leader, 2007-2009
Wave Biotech LLC
Co-Founder, Vice President, 1999-2007
Boards and Other Activities:
Envisagenics, Board Observer, 2017-present
FloDesign Sonics, Board of Directors, 2017-present
Stevens Institute of Technology, Board of Trustees Charter Member, 2016-present
Women in Bio Metro New York Chapter, Founding Committee Member, 2014-2016
Harvard Business School, Executive Education
Private Equity and Venture Capital
Stern School of Business, New York University
Executive MBA, Strategy & Entrepreneurship
Stevens Institute of Technology
BE, Chemical Engineering, BioChemical Engineering